Literature DB >> 15929041

Gene transfer of glutamic acid decarboxylase reduces neuropathic pain.

Shuanglin Hao1, Marina Mata, Darren Wolfe, Shaohua Huang, Joseph C Glorioso, David J Fink.   

Abstract

We tested whether transfer of the gene coding for glutamic acid decarboxylase to dorsal root ganglion using a herpes simplex virus vector to achieve release of GABA in dorsal horn would attenuate nociception in this condition. Subcutaneous inoculation of a replication-defective herpes simplex virus vector expressing glutamic acid decarboxylase (vector QHGAD67) 7 days after selective L5 spinal nerve ligation reversed mechanical allodynia and thermal hyperalgesia; the antiallodynic effect lasted 6 weeks and was reestablished by reinoculation. QHGAD67 inoculation also suppressed induction of c-Fos and phosphorylated extracellular signal-regulated kinase 1 and 2 in the spinal cord.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15929041      PMCID: PMC1242042          DOI: 10.1002/ana.20483

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  20 in total

1.  Transgene-mediated enkephalin release enhances the effect of morphine and evades tolerance to produce a sustained antiallodynic effect in neuropathic pain.

Authors:  Shuanglin Hao; Marina Mata; William Goins; Joseph C Glorioso; David J Fink
Journal:  Pain       Date:  2003-03       Impact factor: 6.961

2.  Spinal GABA(A) and GABA(B) receptor pharmacology in a rat model of neuropathic pain.

Authors:  T Philip Malan; Heriberto P Mata; Frank Porreca
Journal:  Anesthesiology       Date:  2002-05       Impact factor: 7.892

3.  Intravenous morphine does not modify dorsal horn touch-evoked allodynia in the mononeuropathic rat: a Fos study.

Authors:  Gwénaëlle Catheline; Stéphanie Le Guen; Jean-Marie Besson
Journal:  Pain       Date:  2001-06       Impact factor: 6.961

Review 4.  Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action.

Authors:  Søren H Sindrup; Troels S Jensen
Journal:  Pain       Date:  1999-12       Impact factor: 6.961

5.  Therapeutic efficacy in experimental polyarthritis of viral-driven enkephalin overproduction in sensory neurons.

Authors:  J Braz; C Beaufour; A Coutaux; A L Epstein; F Cesselin; M Hamon; M Pohl
Journal:  J Neurosci       Date:  2001-10-15       Impact factor: 6.167

Review 6.  Herpes vector-mediated gene transfer in treatment of diseases of the nervous system.

Authors:  Joseph C Glorioso; David J Fink
Journal:  Annu Rev Microbiol       Date:  2004       Impact factor: 15.500

7.  HSV-mediated gene transfer of the glial cell-derived neurotrophic factor provides an antiallodynic effect on neuropathic pain.

Authors:  Shuanglin Hao; Marina Mata; Darren Wolfe; Shaohua Huang; Joseph C Glorioso; David J Fink
Journal:  Mol Ther       Date:  2003-09       Impact factor: 11.454

8.  Peripherally delivered glutamic acid decarboxylase gene therapy for spinal cord injury pain.

Authors:  Jun Liu; Darren Wolfe; Shuanglin Hao; Shaohua Huang; Joseph C Glorioso; Marina Mata; David J Fink
Journal:  Mol Ther       Date:  2004-07       Impact factor: 11.454

9.  Sevoflurane suppresses noxious stimulus-evoked expression of Fos-like immunoreactivity in the rat spinal cord via activation of endogenous opioid systems.

Authors:  Shuanglin Hao; Osamu Takahata; Keiko Mamiya; Hiroshi Iwasaki
Journal:  Life Sci       Date:  2002-06-21       Impact factor: 5.037

10.  Partial peripheral nerve injury promotes a selective loss of GABAergic inhibition in the superficial dorsal horn of the spinal cord.

Authors:  Kimberly A Moore; Tatsuro Kohno; Laurie A Karchewski; Joachim Scholz; Hiroshi Baba; Clifford J Woolf
Journal:  J Neurosci       Date:  2002-08-01       Impact factor: 6.167

View more
  44 in total

1.  Light touch induces ERK activation in superficial dorsal horn neurons after inflammation: involvement of spinal astrocytes and JNK signaling in touch-evoked central sensitization and mechanical allodynia.

Authors:  Yong-Jing Gao; Ru-Rong Ji
Journal:  J Neurochem       Date:  2010-08-31       Impact factor: 5.372

Review 2.  Viral vector-based gene transfer for treatment of chronic pain.

Authors:  Shuanglin Hao; Marina Mata; David J Fink
Journal:  Int Anesthesiol Clin       Date:  2007

Review 3.  Methods for gene transfer to the central nervous system.

Authors:  Boris Kantor; Rachel M Bailey; Keon Wimberly; Sahana N Kalburgi; Steven J Gray
Journal:  Adv Genet       Date:  2014       Impact factor: 1.944

Review 4.  Progress in gene therapy for neurological disorders.

Authors:  Michele Simonato; Jean Bennett; Nicholas M Boulis; Maria G Castro; David J Fink; William F Goins; Steven J Gray; Pedro R Lowenstein; Luk H Vandenberghe; Thomas J Wilson; John H Wolfe; Joseph C Glorioso
Journal:  Nat Rev Neurol       Date:  2013-04-23       Impact factor: 42.937

Review 5.  Herpes simplex viral vectors: late bloomers with big potential.

Authors:  Joseph C Glorioso
Journal:  Hum Gene Ther       Date:  2014-02       Impact factor: 5.695

6.  Vector-mediated release of GABA attenuates pain-related behaviors and reduces Na(V)1.7 in DRG neurons.

Authors:  Munmun Chattopadhyay; Marina Mata; David J Fink
Journal:  Eur J Pain       Date:  2011-04-12       Impact factor: 3.931

Review 7.  HSV gene transfer in the treatment of chronic pain.

Authors:  David J Fink; Marina Mata
Journal:  Sheng Li Xue Bao       Date:  2008-10-25

8.  Herpes simplex virus vector-mediated delivery of neurturin rescues erectile dysfunction of cavernous nerve injury.

Authors:  R Kato; D Wolfe; C H Coyle; J B Wechuck; P Tyagi; T Tsukamoto; J B Nelson; J C Glorioso; M B Chancellor; N Yoshimura
Journal:  Gene Ther       Date:  2008-07-31       Impact factor: 5.250

9.  Demethylating drugs as novel analgesics for cancer pain.

Authors:  Chi T Viet; Dongmin Dang; Yi Ye; Kentaro Ono; Ronald R Campbell; Brian L Schmidt
Journal:  Clin Cancer Res       Date:  2014-06-24       Impact factor: 12.531

Review 10.  HSV vector-mediated modification of primary nociceptor afferents: an approach to inhibit chronic pain.

Authors:  J R Goss; M S Gold; J C Glorioso
Journal:  Gene Ther       Date:  2009-04       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.